Literature DB >> 871220

Gastrointestinal adaptation following small bowel bypass for obesity.

S J Dudrick, J M Daly, G Castro, M Akhtar.   

Abstract

Small intestinal morphologic and biochemical changes were studied following jejuno-ileal bypass for obesity after body weight stabilization had occurred. Four patients underwent biopsy of in-continuity and bypassed jejunal and ileal segments of the small intestine 11 to 22 months after the bypass operation. Microscopically, marked mucosal villus hypertrophy of the in-continuity bowel was observed, especially in the ileum. Bypassed jejunal mucosa underwent atrophy compared with pre-bypass jejunum, whereas bypassed ileum appeared similar microscopically to pre-bypass ileum. The specific activities of mucosal disaccharidase enzymes (maltase, sucrase, lactase and trehalase) in units per mg protein remained similar to pre-bypass levels in segments of the in-continuity jejunum and the bypassed jejunum and ileum. On the other hand, elevated mucosal disaccharidase levels were measured in biopsy specimens of the in-continuity ileum. Total enzyme activity per unit length of intestine, however, was estimated to be elevated in both in-continuity jejunum and ileum secondary to mucosal villus hypertrophy. These data indicate that following small bowel bypass: (1) the in-continuity ileum undergoes greater biochemical and morphologic adaptation than the jejunum; and (2) intraluminal nutrients and chyme appear to be essential to maximal intestinal adaptation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871220      PMCID: PMC1396225          DOI: 10.1097/00000658-197706000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  EPITHELIAL HYPERPLASIA FOLLOWING MASSIVE SMALL BOWEL RESECTION IN MAN.

Authors:  R L PORUS
Journal:  Gastroenterology       Date:  1965-06       Impact factor: 22.682

2.  Mitotic rates and renewal times of the digestive tract epithelia in the rat.

Authors:  F D BERTALANFFY
Journal:  Acta Anat (Basel)       Date:  1960

3.  Jejunoileal bypass for massive obesity: results and complications in fifty-two patients.

Authors:  E Fikri; R Cassella
Journal:  Ann Surg       Date:  1974-04       Impact factor: 12.969

4.  Biochemical changes in intestinal mucosa after experimental small bowel by-pass in the rat.

Authors:  M H Gleeson; R H Dowling; T J Peters
Journal:  Clin Sci       Date:  1972-12       Impact factor: 6.124

5.  Urinary tract stone after small bowel bypass for morbid obesity.

Authors:  J P O'Leary; W C Thomas; E R Woodward
Journal:  Am J Surg       Date:  1974-02       Impact factor: 2.565

6.  Liver biopsy findings in seventy-seven consecutive patients undergoing jejunoileal bypass for morbid obesity.

Authors:  H Buchwald; P H Lober; R L Varco
Journal:  Am J Surg       Date:  1974-01       Impact factor: 2.565

7.  Hepatic effects of jejunoileal bypass for morbid obesity.

Authors:  R G Brown; J P O'Leary; E R Woodward
Journal:  Am J Surg       Date:  1974-01       Impact factor: 2.565

8.  Intestinal bypass in morbid obesity.

Authors:  P J Corso; W L Joseph
Journal:  Surg Gynecol Obstet       Date:  1974-01

9.  Effect of massive proximal small bowel resection on intestinal sucrase and lactase activity in the rat.

Authors:  W J Bochenek; B Narczewska; M Grzebieluch
Journal:  Digestion       Date:  1973-10       Impact factor: 3.216

10.  Protein nutrition and liver disease after jejunoileal bypass for morbid obesity.

Authors:  R T Moxley; T Pozefsky; D H Lockwood
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

View more
  11 in total

1.  Gut hormones in gastrointestinal disease.

Authors:  H S Besterman
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

Review 2.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

Review 3.  Bile acids and bariatric surgery.

Authors:  Vance L Albaugh; Babak Banan; Hana Ajouz; Naji N Abumrad; Charles R Flynn
Journal:  Mol Aspects Med       Date:  2017-04-17

4.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

5.  Immunoelectrophoretic studies on human small intestinal brush border proteins: cellular alterations in the levels of brush border enzymes after jejunoileal bypass operation.

Authors:  H Skovbjerg; E Gudmand-Høyer; O Norén; H Sjöström
Journal:  Gut       Date:  1980-08       Impact factor: 23.059

6.  Water and electrolyte absorption from a human Thiry-Vella ileal loop. Responses to systemic administration of gastrin, glucagon, secretin, and cholecystokinin.

Authors:  E C Lai; R K Tompkins
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

Review 7.  Intestinal mucosal atrophy and adaptation.

Authors:  Darcy Shaw; Kartik Gohil; Marc D Basson
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

8.  Ileal microbial shifts after Roux-en-Y gastric bypass orchestrate changes in glucose metabolism through modulation of bile acids and L-cell adaptation.

Authors:  Jerry T Dang; Valentin Mocanu; Heekuk Park; Michael Laffin; Caroline Tran; Naomi Hotte; Shahzeer Karmali; Daniel W Birch; Karen Madsen
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

9.  Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin.

Authors:  Gunn Signe Jakobsen; Ine Blankenberg Skottheim; Rune Sandbu; Hege Christensen; Jo Røislien; Anders Asberg; Jøran Hjelmesæth
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

10.  Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.

Authors:  Carl Frederik Hansen; Marco Bueter; Nadine Theis; Thomas Lutz; Sarah Paulsen; Louise S Dalbøge; Niels Vrang; Jacob Jelsing
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.